Original paper

COVID-19 Vaccination and Glomerulonephritis

Volume: 6, Issue: 12, Pages: 2969 - 2978
Published: Dec 1, 2021
Abstract
mRNA COVID-19 vaccine is more effective than traditional vaccines owing to superior immune activation. Nevertheless, the impact of mRNA COVID-19 vaccine on triggering de novo/relapsing glomerulonephritis (GN) is limited. We report a case series of patients who developed new or relapsing GN postvaccination.We evaluated baseline characteristics, vaccine type, and clinical outcomes of 13 patients from our institution who had a new diagnosis or...
Paper Details
Title
COVID-19 Vaccination and Glomerulonephritis
Published Date
Dec 1, 2021
Volume
6
Issue
12
Pages
2969 - 2978
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.